GE HealthCare Technologies Inc.
GEHCHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeHeadquartered within the healthcare sector, GE HealthCare Technologies Inc. focuses on Medical Devices services and products. GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States,. The $28.36B market capitalization puts GEHC squarely in large-cap range for its industry. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
Market Cap
$28.36B
Beta
0.87
P/E (TTM)
14.95
P/E (Fwd)
11.61
EPS (TTM)
$4.17
EPS (Fwd)
$5.37
ROE
19.5%
ROA
5.2%
Cash
$2.26B
Total Debt
$10.58B
Free CF
$1.48B
52W Change
-11.1%
Annual Financials
Cash vs Debt
On the balance sheet, GEHC has $2.26B in cash with $10.58B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $1.48B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 19.5%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 5.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $18.34B to $20.62B.
Investors considering GE HealthCare Technologies Inc. should weigh the typical risks associated with GEHC's sector, size, and financial profile against their own risk tolerance and investment objectives. No single metric tells the full story. Reviewing GEHC's risk profile alongside its fundamentals and technical indicators provides a more complete picture.